Publication | Closed Access
Gabapentin for Chronic Neuropathic Pain
73
Citations
2
References
2018
Year
Oral gabapentin (1200-3600 mg/d for 4-12 weeks) for patients with moderate or severe neuropathic pain from postherpetic neuralgia (PHN) or painful diabetic neuropathy (PDN) is associated with pain reduction of at least 50% in 14% to 17% more patients than placebo.
| Year | Citations | |
|---|---|---|
Page 1
Page 1